Purchase Order 75N91021P00842
Award Date 9/15/21
Potential Completion Date 9/14/23
Potential Value $243K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Columbus, OH 43210, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute (NCI) has awarded a $248,767 firm fixed-price purchase order contract to Proton Doctors Professional Corporation for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. This contract is not set-aside. The goal is to obtain de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Cancer Institute (NCI) to the University of Florida Division of Sponsored Research. The contract has a potential value of $159,826.00 and a period of performance ending on March 15, 2023. The contract is part of the US Pediatric Proton/Photon Therapy Cohort Study, which aims to obtain data on pediatric cancer patients treated with proton or photon therapy. The contract was...
- The National Cancer Institute awarded a $250,000 firm fixed-price purchase order to Baylor College of Medicine on June 27, 2023, to support the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing the risks and benefits of proton versus photon radiation therapy in pediatric cancer patients. Under this non-set-aside contract, Baylor College of Medicine serves as the prime contractor with performance in Houston, Texas, and is scheduled to complete work by June...
- <p>Emory University was awarded a $180,030 firm fixed-price purchase order contract by the National Cancer Institute, part of the U.S. Department of Health and Human Services, to obtain data on a group of proton-treated pediatric cancer patients and a comparison group of photon-treated pediatric cancer patients. The contract is part of the US Pediatric Proton/Photon Therapy Cohort Study major program, with a completion date of January 31, 2024. No set-aside was used for this award.</p>
- The National Cancer Institute (NCI) awarded a $249,997 firm fixed-price purchase order to The Washington University's Office of Sponsored Research Services on November 1, 2024, for medical record abstraction services supporting the Pediatric Proton and Photon Therapy Comparison Cohort study. Under this 14-month contract through June 30, 2026, Washington University will retrieve and abstract de-identified clinical and treatment data from medical records of pediatric cancer patients who received...
- This firm fixed price purchase order awarded by the National Institutes of Health's National Cancer Institute to Mayo Clinic seeks to obtain clinical data on pediatric cancer patients treated with proton therapy or photon therapy. The goal is to retrieve existing diagnosis and treatment data from medical records of eligible patients treated since January 2007 at contractor institutions and enter de-identified data into a secure database to serve as a comparison cohort for a US Pediatric Proton...
- The National Cancer Institute (NCI) awarded a $293,970 firm fixed-price purchase order to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to retrieve existing clinical and treatment data for at least 500 pediatric cancer patients treated with photon therapy since 2007. This data will be used to evaluate photon therapy as a cancer treatment for pediatric patients as part of the U.S. Pediatric Photon Therapy Comparison Cohort Study. The...
- This is a $20,031,230.01 definitive contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to The Ohio State University Research Foundation. The contract is for preclinical efficacy studies and development of biomarker assays, which aligns with NCI's cancer research mission. The Ohio State University Research Foundation has provided technical services as a prime contractor and subcontractor on prior federal contract and grant awards,...
- This firm fixed-price purchase order was awarded by the National Cancer Institute, part of the Department of Health and Human Services, to the University of Utah Office of Sponsored Projects Division. The goal of this $249,996.00 contract is to obtain data on a group of proton-treated pediatric cancer patients and a photon-treated comparison group, to support the U.S. Pediatric Proton/Photon Therapy Cohort Study. No set-aside designation was used. The University of Utah is a top-tier research...
- This is a federal contract award issued by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to The Ohio State University Research Foundation. The contract, valued at $20,352,600.57, is for early therapeutic development with a Phase II emphasis. It is a definitive contract with a cost-no-fee pricing type and has an ultimate completion date of October 31, 2012. The Ohio State University Research Foundation is a U.S. state government entity and 1862 Land Grant...